John W. Smither

Insider Reports History

Location
C/O Kythera Biopharmaceuticals, Inc., 27200 West Agoura Road, Suite 200, Calabasas, CA
Signature
/s/ Thomas Zindrick, J.D. Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John W. Smither:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcutis Biotherapeutics, Inc. Chief Financial Officer Common Stock 141K $501K $3.54 Feb 13, 2024 By Trust
GENELUX Corp Director Common Stock 75K $252K $3.36 Aug 27, 2025 Direct
NewAmsterdam Pharma Co N.V. Director Ordinary Shares 6.96K $178K $25.54 Jan 7, 2025 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Common Stock 11.4K $40.2K $3.54 Feb 13, 2024 Direct
NewAmsterdam Pharma Co N.V. Director Option (right to buy) 32.5K Jan 6, 2025 Direct
GENELUX Corp Director Stock Option (Right to Buy) 28.6K Aug 27, 2025 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Jun 22, 2023 Direct
Applied Molecular Transport Inc. Director Stock Option (Right to Buy) 0 Dec 27, 2023 Direct
Arcutis Biotherapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 0 Feb 13, 2024 Direct

Insider Reports Filed by John W. Smither

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GNLX GENELUX Corp Aug 27, 2025 2 $0 4 Aug 29, 2025 Director
NAMS NewAmsterdam Pharma Co N.V. Jan 6, 2025 2 $0 4 Jan 8, 2025 Director
GNLX GENELUX Corp Aug 1, 2024 1 $0 4/A Dec 31, 2024 Director
GNLX GENELUX Corp May 29, 2024 2 $0 4 Jun 7, 2024 Director
ARQT Arcutis Biotherapeutics, Inc. Feb 13, 2024 4 $0 4 Feb 15, 2024 Chief Financial Officer
NAMS NewAmsterdam Pharma Co N.V. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Dec 29, 2023 0 $0 3 Dec 29, 2023 Director
AMTI Applied Molecular Transport Inc. Dec 27, 2023 3 $0 4 Dec 28, 2023 Director
GNLX GENELUX Corp Sep 13, 2023 1 -$18.7K 4 Sep 14, 2023 Director
GNLX GENELUX Corp Sep 11, 2023 2 $0 4 Sep 13, 2023 Director
GNLX GENELUX Corp Sep 11, 2023 0 $0 3 Sep 13, 2023 Director
ARQT Arcutis Biotherapeutics, Inc. Aug 31, 2023 1 $0 4 Sep 5, 2023 Chief Financial Officer
ARQT Arcutis Biotherapeutics, Inc. Aug 31, 2023 0 $0 3 Sep 5, 2023 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 22, 2023 Director
AMTI Applied Molecular Transport Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Jan 20, 2023 1 $0 4 Jan 24, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
AMTI Applied Molecular Transport Inc. May 24, 2022 1 $0 4 May 26, 2022 Director
AMTI Applied Molecular Transport Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 Director
AMTI Applied Molecular Transport Inc. Jan 27, 2022 0 $0 3 Jan 31, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Oct 6, 2021 1 $0 4 Oct 8, 2021 Director
EFTR eFFECTOR Therapeutics, Inc. Aug 25, 2021 3 $0 4 Aug 27, 2021 Director
EFTR eFFECTOR Therapeutics, Inc. Aug 25, 2020 0 $0 3 Aug 27, 2021 Director